Search research articles
Contact Us
Filters
Showing results (1-10 of 166) with videos related to
Page
of 17
Sort By:
Molecular Medicine (Cambridge, Mass.)
|
July 14, 2009
Molecularly targeted therapies for dysimmune neuropathies
Andreas A Argyriou
European Journal of Cancer Care
|
August 14, 2009
Tracing the incidence of paclitaxel-induced peripheral neuropathy
Andreas A Argyriou
Toxics
|
October 24, 2017
Updates on Oxaliplatin-Induced Peripheral Neurotoxicity (OXAIPN)
Andreas A Argyriou
Reproductive Sciences (Thousand Oaks, Calif.)
|
November 20, 2008
Multiple sclerosis and reproductive risks in women
Andreas A Argyriou, Nicolaos Makris
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 9, 2009
Botulinum toxin type a for painful limbs moving extremities
Andreas A Argyriou, Spyridon Papapetropoulos
Molecular Medicine (Cambridge, Mass.)
|
January 17, 2009
Molecularly targeted therapies for malignant gliomas
Andreas A Argyriou, Haralabos P Kalofonos
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
January 15, 2011
Vitamin E for preventing chemotherapy-induced peripheral neuropathy
Andreas A Argyriou, Haralabos P Kalofonos
Molecular Medicine (Cambridge, Mass.)
|
March 24, 2009
Recent advances relating to the clinical application of naked monoclonal antibodies in solid tumors
Andreas A Argyriou, Haralabos P Kalofonos
Annals of Translational Medicine
|
January 8, 2019
Sphingolipid metabolism products: potential new players in the pathogenesis of bortezomib-induced neuropathic pain
Albert Alé, Andreas A Argyriou, Jordi Bruna
The Oncologist
|
December 7, 2007
The usefulness of nerve conduction studies in objectively assessing oxaliplatin-induced peripheral neuropathy
Andreas A Argyriou, Panagiotis Polychronopoulos, Elisabeth Chroni
Page
of 17
Search research articles
Search
Showing results (1-10 of 166) with videos related to
Sort By:
Page
of 17
Molecular Medicine (Cambridge, Mass.)
|
July 14, 2009
Molecularly targeted therapies for dysimmune neuropathies
Andreas A Argyriou
European Journal of Cancer Care
|
August 14, 2009
Tracing the incidence of paclitaxel-induced peripheral neuropathy
Andreas A Argyriou
Toxics
|
October 24, 2017
Updates on Oxaliplatin-Induced Peripheral Neurotoxicity (OXAIPN)
Andreas A Argyriou
Reproductive Sciences (Thousand Oaks, Calif.)
|
November 20, 2008
Multiple sclerosis and reproductive risks in women
Andreas A Argyriou, Nicolaos Makris
Movement Disorders : Official Journal of the Movement Disorder Society
|
May 9, 2009
Botulinum toxin type a for painful limbs moving extremities
Andreas A Argyriou, Spyridon Papapetropoulos
Molecular Medicine (Cambridge, Mass.)
|
January 17, 2009
Molecularly targeted therapies for malignant gliomas
Andreas A Argyriou, Haralabos P Kalofonos
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
January 15, 2011
Vitamin E for preventing chemotherapy-induced peripheral neuropathy
Andreas A Argyriou, Haralabos P Kalofonos
Molecular Medicine (Cambridge, Mass.)
|
March 24, 2009
Recent advances relating to the clinical application of naked monoclonal antibodies in solid tumors
Andreas A Argyriou, Haralabos P Kalofonos
Annals of Translational Medicine
|
January 8, 2019
Sphingolipid metabolism products: potential new players in the pathogenesis of bortezomib-induced neuropathic pain
Albert Alé, Andreas A Argyriou, Jordi Bruna
The Oncologist
|
December 7, 2007
The usefulness of nerve conduction studies in objectively assessing oxaliplatin-induced peripheral neuropathy
Andreas A Argyriou, Panagiotis Polychronopoulos, Elisabeth Chroni
Page
of 17